HRH3 and Cognitive impairment: Evidence suggests that chronic neuroinflammation may be associated with cognitive deficits, and preclinical studies indicated notably that H3R antagonists/inverse agonists have been found to exhibit mitigating effects on several neuroinflammatory processes and, also, to provide cognition-enhancing properties in preclinical animal models of ASD.